Skip Navigation


NDT Advance Access originally published online on October 26, 2004
Nephrology Dialysis Transplantation 2004 19(12):3005-3011; doi:10.1093/ndt/gfh539
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/12/3005    most recent
gfh539v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Breborowicz, A.
Right arrow Articles by Oreopoulos, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Breborowicz, A.
Right arrow Articles by Oreopoulos, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant Vol. 19 No. 12 © ERA-EDTA 2004; all rights reserved


Original Article

L-2-Oxothiazolidine-4-carboxylic acid reduces in vitro cytotoxicity of glucose degradation products

Andrzej Breborowicz1, Janusz Witowski1, Alicja Polubinska1, Malgorzata Pyda1 and Dimitrios Oreopoulos2

1 Department of Pathophysiology, Poznan Medical School, Poland and 2 Division of Nephrology, University of Toronto, Canada

Correspondence and offprint requests to: Professor Andrzej Breborowicz, Department of Pathophysiology, Poznan Medical School, Ul. Swiecickiego 6, 60–781 Poznan, Poland. Email: abreb{at}am.poznan.pl

Background. Glucose degradation products (GDP) are an important factor that contribute to bioincompatibility of peritoneal dialysis fluids. These substances are generated in the dialysis fluid during heat sterilization. Several approaches have been proposed to reduce the content or toxicity, or both, of GDP present in the dialysis fluid. We examined whether L-2-oxothiazolidine-4-carboxylic acid (OTZ), a precursor for glutathione synthesis, reduces the cytotoxicity of GDP in human peritoneal mesothelial cells.

Methods. Experiments were performed on primary mesothelial cell cultures. Free radical generation in these cells after exposure to acetaldehyde (ACT), glyoxal (GLYO) or methylglyoxal (M-GLYO) was detected with a fluorescent probe. Cell viability measurements were based on release of LDH from cell cytosol, and synthesis of IL-6 and proliferation after exposure to GDP. Effects of individual GDPs and of dialysis fluid free of GDP (GDP-free PDF) or containing GDP (GDP-high PDF) on cell viability were also studied in the presence of OTZ (1 mmol/l).

Results. All of the GDPs as well as the autoclaved dialysis fluid caused increased free radical generation. ACT increased LDH release from the cells by 374% (P<0.001), and this effect was abolished by OTZ. All of the GDPs inhibited cell growth (ACT, 47%, P<0.01; GLYO, 52%, P<0.01; M-GLYO, 26%, P<0.05) and this effect was reversed in presence of OTZ. ACT inhibited Il-6 synthesis in mesothelial cells by 74% P<0.01 and this effect was prevented by OTZ. GDP-high PDF but not GDP-free PDF reduced synthesis of IL-6 in mesothelial cells by 40% (P<0.01) an effect that was reversed by OTZ. Mesothelial cell growth was more strongly inhibited by GDP-high PDF (76%, P<0.01) than by GDP-free PDF (31%, P<0.05). OTZ improved growth of mesothelial cells in the presence of GDP-high PDF (+150%, P<0.01) and in presence of GDP-low PDF (+38%, P<0.05). OTZ prevented the cytotoxic effect of GDP-high PDF on mesothelial cells.

Conclusions. The GDP-induced stimulation of free radicals in mesothelial cells in the present study may provide a possible mechanism of GDP cytotoxicity. Because OTZ reduced the toxic effects of GDP on mesothelial cells, this compound may improve biocompatibility of peritoneal dialysis fluids.

Keywords: glucose degradation products; L-2-othiazolidine-4-carboxylic acid; mesothelium


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Nutr.Home page
N. K. Fukagawa
Sparing of Methionine Requirements: Evaluation of Human Data Takes Sulfur Amino Acids Beyond Protein
J. Nutr., June 1, 2006; 136(6): 1676S - 1681S.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.